Markedly increased levels of PADI2 are detected in hippocampal samples from AD patients, and the immunoreactivity of PADI2 and citrullinated proteins coincides with glial fibrillary acidic protein (GFAP)-positive astrocytes [78]. This evidence concerns the gene PADI2 and Alzheimer disease.